Clinical Proof of Concept of Agluna Silver Antimicrobial Cardiac Pacemakers
149,210
2015-10-01 to 2017-12-31
Launchpad
This project will target development of a pacemaker device treated with Agluna® silver ion antimicrobial surface technology. A parallel development will target a biocompatible, anti-microbial surface on a novel cardiac device. The project will catalyse development of Accentus Cardiac within the South Wales medtech cluster.
Get notified when we’re launching.
Want fast, powerful sales prospecting for UK companies? Signup below to find out when we're live.